These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3419424)

  • 21. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of an effective amphotericin B formulation at high cationic lipid to drug molar ratio.
    Lincopan N; Borelli P; Fock R; Mamizuka EM; Carmona-Ribeiro AM
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):175-83. PubMed ID: 16982179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An effect of antibiotic amphotericin B on ion transport across model lipid membranes and tonoplast membranes.
    Hereć M; Dziubińska H; Trebacz K; Morzycki JW; Gruszecki WI
    Biochem Pharmacol; 2005 Sep; 70(5):668-75. PubMed ID: 16023082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
    Kretschmar M; Nichterlein T; Hannak D; Hof H
    Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic efficiency of amphotericin B liposome modified by RMP-7 to transport drug across blood brain barrier].
    Zhang XB; Yuan S; Lei PC; Hou XP
    Yao Xue Xue Bao; 2004 Apr; 39(4):292-5. PubMed ID: 15303662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in Fungizone toxicity induced by the use of Lipofundin as a dilutent: an in vitro study.
    de Araújo IB; Damasceno BP; de Medeiros TM; Soares LA; do Egito ES
    Curr Drug Deliv; 2005 Apr; 2(2):199-205. PubMed ID: 16305421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.
    Larabi M; Legrand P; Appel M; Gil S; Lepoivre M; Devissaguet J; Puisieux F; Barratt G
    Antimicrob Agents Chemother; 2001 Feb; 45(2):553-62. PubMed ID: 11158754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.
    Bellocchio S; Gaziano R; Bozza S; Rossi G; Montagnoli C; Perruccio K; Calvitti M; Pitzurra L; Romani L
    J Antimicrob Chemother; 2005 Feb; 55(2):214-22. PubMed ID: 15649994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis contributes to amphotericin B-induced nephrotoxicity.
    Varlam DE; Siddiq MM; Parton LA; Rüssmann H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):679-85. PubMed ID: 11181342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ liposomal preparation containing amphotericin B: related toxicity and tissue disposition studies.
    Chakraborty KK; Naik SR
    Pharm Dev Technol; 2000; 5(4):543-53. PubMed ID: 11109253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats.
    Wasan KM; Vadiei K; Lopez-Berestein G; Luke DR
    J Infect Dis; 1990 Mar; 161(3):562-6. PubMed ID: 2313133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen.
    Boggs JM; Chang NH; Goundalkar A
    Antimicrob Agents Chemother; 1991 May; 35(5):879-85. PubMed ID: 1854170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B.
    Wasan KM; Rosenblum MG; Cheung L; Lopez-Berestein G
    Antimicrob Agents Chemother; 1994 Feb; 38(2):223-7. PubMed ID: 8192447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.
    Jullien S; Brajtburg J; Bolard J
    Biochim Biophys Acta; 1990 Jan; 1021(1):39-45. PubMed ID: 2403812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells.
    Mehta R; Lopez-Berestein G; Hopfer R; Mills K; Juliano RL
    Biochim Biophys Acta; 1984 Mar; 770(2):230-4. PubMed ID: 6696909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical changes in the kidney cells of dogs after the intravenous administration of deoxycholate sodium (the nephrotoxic action of amphotericin B)].
    Kravchenko LS
    Antibiotiki; 1977 Mar; 22(3):233-8. PubMed ID: 848917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.
    Szoka FC; Milholland D; Barza M
    Antimicrob Agents Chemother; 1987 Mar; 31(3):421-9. PubMed ID: 3579259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.